ACTIVE

Dr. E. JOUSTEN Endokrinologie

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result153,6 k €-4,5 %over 1 year
Gross margin194 k €-11,7 %over 1 year
Equity475,6 k €-20,0 %over 1 year

Identity

Source · BCE/KBO

Dr. E. JOUSTEN Endokrinologie is a Private limited company incorporated in 2010. Its registered office is in Eupen.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0831.645.831
Incorporation
06/12/2010
Legal form
Private limited company
Registered office
Rue Haute 58
4700 Eupen · WallonieSee on map
Contributed capital
1 000,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 16 filings

Trend over 16 financial years

20252024202320222021
Income statement
Gross margin194 k €219,8 k €221 k €149,9 k €150,8 k €
EBITDA193,9 k €219,6 k €220,6 k €149,4 k €150,3 k €
Operating result190,3 k €215,6 k €218,9 k €137 k €138,7 k €
Net result153,6 k €160,9 k €160,1 k €94,8 k €97,7 k €
Balance sheet
Equity475,6 k €594,6 k €499,5 k €390,3 k €355,6 k €
Total assets587,1 k €699,4 k €577,3 k €478,9 k €444,8 k €
Cash77,3 k €62,5 k €45,2 k €283,5 k €242,6 k €
Debts111,5 k €104,8 k €77,8 k €88,6 k €89,2 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 3 ended

Active mandates

Esther Dr. Jousten

Director · since 01 décembre 2010

Active

Ended mandates

Esther Dr. Jousten

Director · since 01 décembre 2010 · until 16 mai 2025

Ended
Esther DR Jousten

Manager

Ended
Esther Dr. Jousten

Manager

Ended

Other companies at this address

Rue Haute 58 4700 Eupen
CompanyCBE no.
De Maenneleins V.o.G.● Active
0545.733.084

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date23/06/202611/06/202510/06/202414/06/202331/05/202204/06/2021
General meeting12/06/202606/06/202507/06/202402/06/202320/05/202201/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 16 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202512/06/202623/06/2026GermanPDF
Micro model31/12/202406/06/202511/06/2025GermanPDF
Micro model31/12/202307/06/202410/06/2024GermanPDF
Micro model31/12/202202/06/202314/06/2023GermanPDF
Micro model31/12/202120/05/202231/05/2022GermanPDF
Micro model31/12/202001/06/202104/06/2021GermanPDF
Micro model31/12/201929/05/202002/06/2020GermanPDF
Micro model31/12/201820/06/201928/06/2019GermanPDF
Micro model31/12/201718/06/201813/07/2018GermanPDF
Micro model31/12/201619/05/201705/07/2017GermanPDF
Abridged model31/12/201520/05/201623/06/2016GermanPDF
Abridged model31/12/201415/05/201527/07/2015GermanPDF
Abridged model31/12/201330/06/201410/07/2014GermanPDF
Abridged model31/12/201217/05/201302/07/2013GermanPDF
Abridged model31/12/201118/05/201225/07/2012GermanPDF
Abridged model31/12/201020/05/201125/07/2011GermanPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 3 ended

Active mandates

Esther Dr. Jousten

Director · since 01 décembre 2010

Active

Ended mandates

Esther Dr. Jousten

Director · since 01 décembre 2010 · until 16 mai 2025

Ended
Esther DR Jousten

Manager

Ended
Esther Dr. Jousten

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates22/09/2022
    SATZUNGEN (UEBERSETZUNG, KOORDINATION, ANDERE AENDERUNGEN, …) - AENDERUNG RECHTSFORM - GESELLSCHAFTSNAME - VERSCHIEDENES - ENTLASSUNG - ERNENNUNG - GENERALVERSAMMLUNG
    PDF
  • Other07/09/2012
    VERSCHIEDENES
    PDF
  • Other16/12/2010
    RUBRIK GRUENDUNG (NEUE RECHTSPERSON, EROEFFNUNG FILIALE, USW)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025153,6 k €↓
  2. 2024
    Annual accounts 2024160,9 k €↑
  3. 2024
    Name changeDr. E. Jousten Endokrinologie GmbH
  4. 2023
    Annual accounts 2023160,1 k €↑
  5. 2022
    Annual accounts 202294,8 k €↓
  6. 2021
    Annual accounts 202197,7 k €↑
  7. 2021
    Name changeDr. E. Jousten Endokrinologie
  8. 2020
    Annual accounts 202081,8 k €↑
  9. 2019
    Annual accounts 201966,6 k €↑
  10. 2018
    Annual accounts 201851,3 k €↑
  11. 2017
    Annual accounts 201746,8 k €↓
  12. 2016
    Annual accounts 201648,6 k €↑
  13. 2015
    Annual accounts 201538,9 k €↓
  14. 2014
    Annual accounts 201441,4 k €↑
  15. 2013
    Annual accounts 201326,8 k €↓
  16. 2012
    Annual accounts 201235,7 k €↓
  17. 2011
    Annual accounts 201139,9 k €↑
  18. 2010
    Annual accounts 201021,7 k €
  19. 06/12/2010
    IncorporationPrivate limited company
  20. 2010
    Name changeDr. Esther JOUSTEN Endokrinologie